Schonfeld Strategic Advisors LLC Invitae Corp Transaction History

Schonfeld Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $18,064 - $38,136	-10,564 Reduced 8.34%	116,049 $215,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $687,148 - $3.12 Million	-361,657 Reduced 74.07%	126,613 $312,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $989,706 - $4.19 Million	464,651 Added 1967.28%	488,270 $1.19 Million
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $148,327 - $368,220	23,619 New	23,619 $188,000
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $437,573 - $642,535	-11,194 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $318,245 - $500,035	11,194 New	11,194 $0
Q1 2019 May 15, 2019	SELL	$10.65 - $25.75 $1.03 Million - $2.49 Million	-96,883 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$9.26 - $16.38 $897,136 - $1.59 Million	96,883 New	96,883 $1.07 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.